Danishevich, A.; Chegodar, A.; Bodunova, N.; Konovalov, F.; Nefedova, M.; Kremneva, N.; Kurbanov, N.; Bilyalov, A.; Nikolaev, S.; Khatkov, I.;
et al. Myelodysplastic Syndrome: Clinical Characteristics and Significance of Preclinically Detecting Biallelic Mutations in the TET2 Gene. Life 2024, 14, 637.
https://doi.org/10.3390/life14050637
AMA Style
Danishevich A, Chegodar A, Bodunova N, Konovalov F, Nefedova M, Kremneva N, Kurbanov N, Bilyalov A, Nikolaev S, Khatkov I,
et al. Myelodysplastic Syndrome: Clinical Characteristics and Significance of Preclinically Detecting Biallelic Mutations in the TET2 Gene. Life. 2024; 14(5):637.
https://doi.org/10.3390/life14050637
Chicago/Turabian Style
Danishevich, Anastasiia, Anzhelika Chegodar, Natalia Bodunova, Fedor Konovalov, Maria Nefedova, Natalya Kremneva, Nizhat Kurbanov, Airat Bilyalov, Sergey Nikolaev, Igor Khatkov,
and et al. 2024. "Myelodysplastic Syndrome: Clinical Characteristics and Significance of Preclinically Detecting Biallelic Mutations in the TET2 Gene" Life 14, no. 5: 637.
https://doi.org/10.3390/life14050637
APA Style
Danishevich, A., Chegodar, A., Bodunova, N., Konovalov, F., Nefedova, M., Kremneva, N., Kurbanov, N., Bilyalov, A., Nikolaev, S., Khatkov, I., & Dudina, G.
(2024). Myelodysplastic Syndrome: Clinical Characteristics and Significance of Preclinically Detecting Biallelic Mutations in the TET2 Gene. Life, 14(5), 637.
https://doi.org/10.3390/life14050637
